{"id":"https://openalex.org/W3122836723","doi":"https://doi.org/10.2174/1381612827666210114150607","title":"Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections","display_name":"Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections","publication_year":2021,"publication_date":"2021-01-18","ids":{"openalex":"https://openalex.org/W3122836723","doi":"https://doi.org/10.2174/1381612827666210114150607","mag":"3122836723","pmid":"https://pubmed.ncbi.nlm.nih.gov/33459225"},"language":"en","primary_location":{"id":"doi:10.2174/1381612827666210114150607","doi":"https://doi.org/10.2174/1381612827666210114150607","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612827666210114150607","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070045140","display_name":"Arquimedes Gasparotto","orcid":"https://orcid.org/0000-0003-3433-5098","observed_orcids":["https://orcid.org/0000-0003-3433-5098"]},"institutions":[{"id":"https://openalex.org/I187420256","display_name":"Universidade Federal da Grande Dourados","ror":"https://ror.org/0310smc09","country_code":"BR","type":"education","lineage":["https://openalex.org/I187420256"]}],"countries":["BR"],"is_corresponding":true,"raw_author_name":"Arquimedes Gasparotto Junior","raw_affiliation_strings":["Laboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS,Brazil"],"raw_orcid":"https://orcid.org/0000-0003-3433-5098","affiliations":[{"raw_affiliation_string":"Laboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS,Brazil","institution_ids":["https://openalex.org/I187420256"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033528630","display_name":"Sara Em\u00edlia Lima Tolouei","orcid":"https://orcid.org/0000-0002-5147-6434","observed_orcids":["https://orcid.org/0000-0002-5147-6434"]},"institutions":[{"id":"https://openalex.org/I52418104","display_name":"Universidade Federal do Paran\u00e1","ror":"https://ror.org/05syd6y78","country_code":"BR","type":"education","lineage":["https://openalex.org/I52418104"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Sara Em\u00edlia Lima Tolouei","raw_affiliation_strings":["Laboratory of Reproductive Toxicology, Department of Pharmacology, Federal University of Paran\u00e1, Curitiba, PR,Brazil"],"raw_orcid":"https://orcid.org/0000-0002-5147-6434","affiliations":[{"raw_affiliation_string":"Laboratory of Reproductive Toxicology, Department of Pharmacology, Federal University of Paran\u00e1, Curitiba, PR,Brazil","institution_ids":["https://openalex.org/I52418104"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085792576","display_name":"Francislaine Aparecida dos Reis L\u00edvero","orcid":"https://orcid.org/0000-0001-6533-0850","observed_orcids":["https://orcid.org/0000-0001-6533-0850"]},"institutions":[{"id":"https://openalex.org/I187576290","display_name":"Universidade Paranaense","ror":"https://ror.org/0084z7g54","country_code":"BR","type":"education","lineage":["https://openalex.org/I187576290"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Francislaine Aparecida dos Reis L\u00edvero","raw_affiliation_strings":["Laboratory of Preclinical Research of Natural Products, Post-Graduate Program in Medicinal Plants and Phytotherapeutics in Basic Attention, Paranaense University, Umuarama, PR,Brazil"],"raw_orcid":"https://orcid.org/0000-0001-6533-0850","affiliations":[{"raw_affiliation_string":"Laboratory of Preclinical Research of Natural Products, Post-Graduate Program in Medicinal Plants and Phytotherapeutics in Basic Attention, Paranaense University, Umuarama, PR,Brazil","institution_ids":["https://openalex.org/I187576290"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035523994","display_name":"Francielli Gasparotto","orcid":"https://orcid.org/0000-0002-4038-7364","observed_orcids":["https://orcid.org/0000-0002-4038-7364"]},"institutions":[{"id":"https://openalex.org/I3018588415","display_name":"Centro Universit\u00e1rio Cesumar","ror":"https://ror.org/03byjr489","country_code":"BR","type":"education","lineage":["https://openalex.org/I3018588415"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Francielli Gasparotto","raw_affiliation_strings":["Cesumar Institute of Science, Technology and Innovation (ICETI), University Center of Maringa, Maringa, PR,Brazil"],"raw_orcid":"https://orcid.org/0000-0002-4038-7364","affiliations":[{"raw_affiliation_string":"Cesumar Institute of Science, Technology and Innovation (ICETI), University Center of Maringa, Maringa, PR,Brazil","institution_ids":["https://openalex.org/I3018588415"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085060597","display_name":"Thaise Boeing","orcid":"https://orcid.org/0000-0002-3793-6166","observed_orcids":["https://orcid.org/0000-0002-3793-6166"]},"institutions":[{"id":"https://openalex.org/I17974374","display_name":"Universidade de S\u00e3o Paulo","ror":"https://ror.org/036rp1748","country_code":"BR","type":"education","lineage":["https://openalex.org/I17974374"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Thaise Boeing","raw_affiliation_strings":["School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP,Brazil"],"raw_orcid":"https://orcid.org/0000-0002-3793-6166","affiliations":[{"raw_affiliation_string":"School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP,Brazil","institution_ids":["https://openalex.org/I17974374"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078046541","display_name":"Priscila de Souza","orcid":"https://orcid.org/0000-0002-5251-5642","observed_orcids":["https://orcid.org/0000-0002-5251-5642"]},"institutions":[{"id":"https://openalex.org/I4210144729","display_name":"Universidade do Vale do Itaja\u00ed","ror":"https://ror.org/041pjwa23","country_code":"BR","type":"education","lineage":["https://openalex.org/I4210144729"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Priscila de Souza","raw_affiliation_strings":["Postgraduate Program in Pharmaceutical Sciences, University of Vale do Itajai, Itajai, SC,Brazil"],"raw_orcid":"https://orcid.org/0000-0002-5251-5642","affiliations":[{"raw_affiliation_string":"Postgraduate Program in Pharmaceutical Sciences, University of Vale do Itajai, Itajai, SC,Brazil","institution_ids":["https://openalex.org/I4210144729"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5070045140"],"corresponding_institution_ids":["https://openalex.org/I187420256"],"apc_list":null,"apc_paid":null,"fwci":1.2192,"has_fulltext":false,"cited_by_count":49,"citation_normalized_percentile":{"value":0.7781018,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"27","issue":"13","first_page":"1588","last_page":"1596"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.5874000191688538,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.5874000191688538,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12257","display_name":"Bioactive natural compounds","score":0.10499999672174454,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.0812000036239624,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9559999704360962},{"id":"https://openalex.org/keywords/ace2","display_name":"ACE2","score":0.8730000257492065},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.6779999732971191},{"id":"https://openalex.org/keywords/natural-compounds","display_name":"natural compounds","score":0.875},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.7870000004768372},{"id":"https://openalex.org/keywords/phenolic-compounds","display_name":"phenolic compounds","score":0.828000009059906},{"id":"https://openalex.org/keywords/terpenoids","display_name":"terpenoids","score":0.9210000038146973},{"id":"https://openalex.org/keywords/alkaloids","display_name":"alkaloids","score":0.9879999756813049},{"id":"https://openalex.org/keywords/quercetin","display_name":"quercetin","score":0.9390000104904175},{"id":"https://openalex.org/keywords/curcumin","display_name":"curcumin","score":0.996999979019165},{"id":"https://openalex.org/keywords/naringenin","display_name":"naringenin","score":0.7749999761581421},{"id":"https://openalex.org/keywords/luteolin","display_name":"luteolin","score":0.8690000176429749},{"id":"https://openalex.org/keywords/hesperidin","display_name":"hesperidin","score":0.9760000109672546},{"id":"https://openalex.org/keywords/mangiferin","display_name":"mangiferin","score":0.972000002861023},{"id":"https://openalex.org/keywords/gallic-acid","display_name":"gallic acid","score":0.9319999814033508},{"id":"https://openalex.org/keywords/esculetin","display_name":"esculetin","score":0.9869999885559082},{"id":"https://openalex.org/keywords/nimbin","display_name":"nimbin","score":0.9369999766349792},{"id":"https://openalex.org/keywords/withaferin-a","display_name":"withaferin A","score":0.9950000047683716},{"id":"https://openalex.org/keywords/andrographolide","display_name":"andrographolide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/zingiberene","display_name":"zingiberene","score":0.9679999947547913},{"id":"https://openalex.org/keywords/berberine","display_name":"berberine","score":0.996999979019165},{"id":"https://openalex.org/keywords/piperine","display_name":"piperine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/thebaine","display_name":"thebaine","score":0.9779999852180481},{"id":"https://openalex.org/keywords/magnolol","display_name":"magnolol","score":0.7689999938011169},{"id":"https://openalex.org/keywords/resveratrol","display_name":"resveratrol","score":0.996999979019165},{"id":"https://openalex.org/keywords/rosmarinic-acid","display_name":"rosmarinic acid","score":1.0},{"id":"https://openalex.org/keywords/tanshinone-iia","display_name":"tanshinone IIA","score":0.9959999918937683},{"id":"https://openalex.org/keywords/nicotine","display_name":"nicotine","score":0.9490000009536743},{"id":"https://openalex.org/keywords/antiviral-agents","display_name":"antiviral agents","score":0.6489999890327454}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7005653977394104},{"id":"https://openalex.org/C2778173338","wikidata":"https://www.wikidata.org/wiki/Q951449","display_name":"Myricetin","level":5,"score":0.5658822059631348},{"id":"https://openalex.org/C2777252647","wikidata":"https://www.wikidata.org/wiki/Q411310","display_name":"Hesperetin","level":4,"score":0.536733865737915},{"id":"https://openalex.org/C2780133158","wikidata":"https://www.wikidata.org/wiki/Q414501","display_name":"Piperine","level":2,"score":0.5224358439445496},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.5032274127006531},{"id":"https://openalex.org/C2779396153","wikidata":"https://www.wikidata.org/wiki/Q901227","display_name":"Natural product","level":2,"score":0.4794656038284302},{"id":"https://openalex.org/C2776128092","wikidata":"https://www.wikidata.org/wiki/Q385937","display_name":"Hesperidin","level":3,"score":0.4742159843444824},{"id":"https://openalex.org/C2778250585","wikidata":"https://www.wikidata.org/wiki/Q312266","display_name":"Curcumin","level":2,"score":0.46778878569602966},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4608786404132843},{"id":"https://openalex.org/C2781263971","wikidata":"https://www.wikidata.org/wiki/Q409478","display_name":"Quercetin","level":3,"score":0.4406725764274597},{"id":"https://openalex.org/C158180186","wikidata":"https://www.wikidata.org/wiki/Q278487","display_name":"PubChem","level":2,"score":0.4275052547454834},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3926490545272827},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3616936504840851},{"id":"https://openalex.org/C2779054382","wikidata":"https://www.wikidata.org/wiki/Q72185287","display_name":"Flavonoid","level":3,"score":0.260434627532959},{"id":"https://openalex.org/C2778004101","wikidata":"https://www.wikidata.org/wiki/Q133948","display_name":"Antioxidant","level":2,"score":0.22211599349975586},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2777810353","wikidata":"https://www.wikidata.org/wiki/Q393336","display_name":"Kaempferol","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000085962","descriptor_name":"Angiotensin-Converting Enzyme 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/1381612827666210114150607","doi":"https://doi.org/10.2174/1381612827666210114150607","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612827666210114150607","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},{"id":"pmid:33459225","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33459225","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current pharmaceutical design","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2167404990","display_name":null,"funder_award_id":"449464/2014\u20138","funder_id":"https://openalex.org/F4320322025","funder_display_name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico"},{"id":"https://openalex.org/G3081603928","display_name":null,"funder_award_id":"407685/2018-9","funder_id":"https://openalex.org/F4320322025","funder_display_name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico"},{"id":"https://openalex.org/G6645238023","display_name":null,"funder_award_id":"59/300.046/2015","funder_id":"https://openalex.org/F4320323354","funder_display_name":"Funda\u00e7\u00e3o de Apoio ao Desenvolvimento do Ensino, Ci\u00eancia e Tecnologia do Estado de Mato Grosso do Sul"},{"id":"https://openalex.org/G8747169735","display_name":null,"funder_award_id":"71/700.135/2018","funder_id":"https://openalex.org/F4320323354","funder_display_name":"Funda\u00e7\u00e3o de Apoio ao Desenvolvimento do Ensino, Ci\u00eancia e Tecnologia do Estado de Mato Grosso do Sul"}],"funders":[{"id":"https://openalex.org/F4320322025","display_name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","ror":"https://ror.org/03swz6y49"},{"id":"https://openalex.org/F4320323354","display_name":"Funda\u00e7\u00e3o de Apoio ao Desenvolvimento do Ensino, Ci\u00eancia e Tecnologia do Estado de Mato Grosso do Sul","ror":"https://ror.org/05jtrt935"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":60,"referenced_works":["https://openalex.org/W1514305176","https://openalex.org/W1876811656","https://openalex.org/W1973662896","https://openalex.org/W1973809240","https://openalex.org/W1992203795","https://openalex.org/W2007679990","https://openalex.org/W2041603866","https://openalex.org/W2044549602","https://openalex.org/W2045076711","https://openalex.org/W2055549259","https://openalex.org/W2080088910","https://openalex.org/W2086345815","https://openalex.org/W2092101309","https://openalex.org/W2092485104","https://openalex.org/W2092835066","https://openalex.org/W2101408959","https://openalex.org/W2113498855","https://openalex.org/W2163329609","https://openalex.org/W2231588589","https://openalex.org/W2299953595","https://openalex.org/W2337855427","https://openalex.org/W2416839162","https://openalex.org/W2494928408","https://openalex.org/W2497451167","https://openalex.org/W2508430363","https://openalex.org/W2514263817","https://openalex.org/W2573565292","https://openalex.org/W2601288326","https://openalex.org/W2605705684","https://openalex.org/W2618061614","https://openalex.org/W2724622383","https://openalex.org/W2728145659","https://openalex.org/W2757846252","https://openalex.org/W2793725413","https://openalex.org/W2803627340","https://openalex.org/W2804217999","https://openalex.org/W2807364816","https://openalex.org/W2883410184","https://openalex.org/W2885396126","https://openalex.org/W2890462823","https://openalex.org/W2895701167","https://openalex.org/W2899473641","https://openalex.org/W3004280078","https://openalex.org/W3008090866","https://openalex.org/W3008142620","https://openalex.org/W3009799538","https://openalex.org/W3009980084","https://openalex.org/W3010441732","https://openalex.org/W3011376519","https://openalex.org/W3013302817","https://openalex.org/W3016010853","https://openalex.org/W3017633633","https://openalex.org/W3017868152","https://openalex.org/W3018448193","https://openalex.org/W3019779428","https://openalex.org/W3023882886","https://openalex.org/W3026512259","https://openalex.org/W3035876959","https://openalex.org/W3036688391","https://openalex.org/W3041160518"],"related_works":["https://openalex.org/W4386527872","https://openalex.org/W4400730824","https://openalex.org/W7214615239","https://openalex.org/W4224949058","https://openalex.org/W4200190633","https://openalex.org/W3007533211","https://openalex.org/W4367845973","https://openalex.org/W4221097605","https://openalex.org/W3113615604","https://openalex.org/W3081665678"],"abstract_inverted_index":{"One":[0],"of":[1,5,13,71,103,117,144,229,271],"the":[2,11,51,69,100,114,141,148,212,231,263,267],"biggest":[3],"challenges":[4],"public":[6],"health":[7],"worldwide":[8],"is":[9,242],"reducing":[10,62],"number":[12],"events":[14],"and":[15,64,164,176,186,196,217,223,258,273],"deaths":[16],"related":[17,98],"to":[18,77,83,87,94,99,244,265],"severe":[19],"acute":[20],"respiratory":[21],"syndrome":[22],"coronavirus":[23],"2":[24,30],"(SARS-CoV-2)":[25],"infections.":[26],"The":[27],"angiotensinconverting":[28],"enzyme":[29],"(ACE-2),":[31],"a":[32,45,58,80,200],"carboxypeptidase":[33],"that":[34,127,246],"degrades":[35],"angiotensin":[36,39],"II":[37],"into":[38],"1-7,":[40],"has":[41,56,74],"been":[42,75],"identified":[43],"as":[44,79,106,237,251],"potent":[46],"receptor":[47],"for":[48,120,214],"SARS-CoV-2.":[49],"In":[50],"last":[52],"decades,":[53],"ACE":[54,239],"inhibition":[55],"assumed":[57],"central":[59],"role":[60],"in":[61,113,122,151,174,182,207],"cardiovascular":[63],"renal":[65],"events.":[66],"However,":[67],"with":[68,170,203],"advent":[70],"COVID-19,":[72],"attention":[73],"turned":[76],"ACE-2":[78,172,180,205,228],"possible":[81],"target":[82,173,206],"reduce":[84],"virus":[85],"binding":[86,168,201],"different":[88],"human":[89],"cells.":[90],"This":[91],"review":[92],"aims":[93],"discuss":[95],"recent":[96],"developments":[97],"medicinal":[101],"properties":[102],"natural":[104,133,248],"compounds":[105,129,149,222,233,249],"ACE/ACE-2":[107],"inhibitors,":[108],"which":[109,139],"should":[110],"be":[111],"highlighted":[112],"future":[115,215],"development":[116],"studies":[118,219],"looking":[119],"modulators":[121],"SARS-CoV-2":[123,277],"infection.":[124,278],"Data":[125],"show":[126],"bioactive":[128],"isolated":[130],"from":[131],"several":[132],"products":[134],"act":[135],"by":[136],"inhibiting":[137],"ACE/ACE-2,":[138],"changes":[140],"entire":[142],"axis":[143],"this":[145,152],"system.":[146],"Of":[147],"addressed":[150],"review,":[153],"7":[154],"phenolic":[155],"compounds,":[156],"including":[157],"quercetin,":[158],"curcumin,":[159],"naringenin,":[160],"luteolin,":[161],"hesperidin,":[162],"mangiferin,":[163],"gallic":[165],"acid":[166],"showed":[167,199],"affinity":[169,202],"molecular":[171,204],"silico,":[175],"1,":[177],"esculetin,":[178],"decreased":[179],"expression":[181,270],"vivo.":[183],"Regarding":[184],"terpenoids":[185],"alkaloids,":[187],"nimbin,":[188],"withaferin":[189],"A,":[190],"andrographolide,":[191],"zingiberene":[192],"and,":[193],"berberine,":[194],"piperine":[195],"thebaine,":[197],"respectively,":[198],"silico.":[208],"These":[209],"findings":[210],"reinforce":[211],"need":[213],"preclinical":[216],"clinical":[218],"on":[220,227],"these":[221],"specific":[224],"inhibitory":[225],"effects":[226],"all":[230],"other":[232],"described":[234],"herein":[235],"only":[236],"nonspecific":[238],"inhibitors.":[240],"It":[241],"important":[243],"mention":[245],"some":[247],"such":[250],"magnolol,":[252],"resveratrol,":[253],"rosmarinic":[254],"acid,":[255],"tanshinone":[256],"IIA,":[257],"nicotine":[259],"have":[260],"also":[261],"demonstrated":[262],"potential":[264],"increase":[266],"activity":[268],"or":[269],"ACE-2,":[272],"could":[274],"therefore":[275],"aggravate":[276]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":15}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2021-02-01T00:00:00"}